2-chloro-N-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidin-4-amine, 95%, 1g

3-Iodo-1H-indazole, 95.0%, 10g

1,1'-Dibenzoylferrocene>98.0%(HPLC)5g

(R)-7-(But-2-yn-1-yl)-8-(3-hydroxypiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (Linagliptin Impurity), 97%, 50mg

2-Chloro-3-methylisonicotinic acid, 95.0%, 1g

4-(2-methyl-1,3-thiazol-4-yl)phenol, 98.0%, 250mg

1-isobutyl-1H-benzimidazol-2-amine, 95.0%, 5g

tert-butyl (2S)-2-[4-(4-iodophenyl)-1H-imidazol-2-yl]pyrrolidine-1-carboxylate, 97%, 100mg

tert-butyl 2-(aminomethyl)-1-oxa-8-azaspiro[4.5]decane-8-carboxylate hydrochloride, 100mg

N-(2-Aminophenyl)-6-[(7-methoxy-4-quinolinyl)oxy]-1-naphthalenecarboxamide, 95%+, 50mg

Ethyl 5-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 95.0%, 5g

2-(2-Pyridyl)aniline, 97.0%, 1g

1-N-Cbz-3-Hydroxyazetidine, 96.0%, 25g